Hôpital Saint Louis

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, acute myeloid leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 3	2026-10-07	NCT07007312
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer	Hot Flashes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms	Active, not recruiting	Phase 3	2026-07-09	NCT05587296
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer	cancer, neoplasm	Active, not recruiting	Phase 3	2026-07-07	NCT04464226
Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.	Prevention	Not yet recruiting	Phase 3	2024-02-23	NCT06273943

Clinical trials